Loading company…
US-based regenerative medicine company whose RejuvaKnee implant is cleared by the FDA for meniscal repair.
Regenity Biosciences develops regenerative medicine products, including the RejuvaKnee implant, an FDA-cleared device for meniscal repair, and bioresorbable and biocompatible synthetic polymers from its Polyganics acquisition, used in ENT, neurosurgery and general surgery. Founded in 1997 as Collagen Matrix, Inc., the company is based in Paramus, US, and its leadership team includes Barbara Cai, Shawn McCarthy and Vladimir Kirilov. In February 2026 Cinven agreed to invest, with Linden Capital Partners reinvesting, and financial terms were not disclosed. The company is at Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in